Mapfre

COVID-19 fragility

26/03/20 -"The reduction in our target price was driven by lower earnings for 2020-22 and the increase in the discount, attributed to P/Book, P/E and dividend yield relative to its peers, from 20% to 40%. This ..."

PDF page sample
Pages
52
Language
English
Published on
26/03/20
Download
You may also be interested by these reports :
04/09/26
MPS is proposing to launch two public exchange offers, for Banca Generali and Banco BPM, as a countermove to Intesa Sanpaolo’s takeover bid. In our ...
02/09/26
Swiss Life reported 1H26 results, which were broadly in line with our estimates and slightly above consensus. The segment result included both ...
28/08/26
Ageas reported good 1H26 results, with strong inflows, particularly in Life in Europe, and an increase in the net operating result despite ...
27/08/26
EssilorLuxottica (EL) (BUY; France) share price peaked in late 2025 and has shed 40% ytd. No small feat for a stock that used to be worth more than ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO